The Ministry of Health and Long-Term Care's Assistive Devices Program provides customer centered support and funding to Ontario residents who have long-term physical disabilities to provide access to personalized assistive devices appropriate for the individual's basic needs. To accomplish this goal the ADP must establish relationships with health professionals in order to ensure that ADP clients are assessed for cost-effective devices that best suit their needs.
Application for Funding Mobility Devices
The purpose of the e-Form is to assist physicians in the EAP drug request process by integrating all the rules/criteria into an interactive e-Form that will ensure all the necessary information is captured.
The purpose of the e-Form is to assist physicians in the EAP drug request process by integrating all the rules/criteria into an interactive e-Form that will ensure all the necessary information is captured.
Used for obtaining authorization for allergen exact as an ODB benefit
This form is used by Manufacturer's Testing Facilities to report testing of Ambulation Aids
The purpose of the e-Form is to assist physicians in the EAP drug request process by integrating all the rules/criteria into an interactive e-Form that will ensure all the necessary information is captured.
Application used to determine eligibility for funding by ADP for Hearing Devices.
Healthy Smiles Ontario Application Through Guarantor form for the core services stream of the program. This form applies to applicants who do not have a valid SIN or have not filed taxes with the CRA, and a guarantor is required to support registration and eligibility adjudication.
Form authorizes the ministry to disclose an individual's personal claims history information directly to a third party.
To be used for all applications for Home Oxygen Therapy funding.
For retailers that primarily sell vapour products to apply for a specialty vape store registration.
Form used by physicians to make inquiries regarding payment details on Remittance Advice
Consent Form for the Inherited Metabolic Diseases (IMD) Program